| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 546.3K | $16.74M | - | |
| VP | 263.8K | $8.08M | - | |
| VP | 76.9K | $2.36M | - | |
| CFO | 75.9K | $2.33M | - | |
| Dir | 30.0K | $918.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 25, 2019 | John S Stafford III46 | 10% Owner | Buy | 5,500 | $29.84 | $164,115.00 | +0.1% | |
| Mar 18, 2019 | John S Stafford III46 | 10% Owner | Buy | 39,400 | $29.04 | $1,144,356.00 | +0.8% | |
| Sep 17, 2018 | Paul A Foster | Chief Medical Officer | Sale+OE | 40,000 | $46.03 | $1,841,208.00 | -89.0% | |
| Sep 14, 2018 | John S Stafford III46 | 10% Owner | Sell | 1,000 | $48.05 | $48,054.00 | - | |
| Aug 17, 2018 | Paul A Foster | Chief Medical Officer | Sale+OE | 3,659 | $40.10 | $146,725.90 | -42.5% | |
| Aug 16, 2018 | Paul A Foster | Chief Medical Officer | Sale+OE | 36,341 | $41.10 | $1,493,709.63 | -88.0% | |
| Aug 13, 2018 | Edgardo Baracchini Jr. | Chief Business Officer | Sale+OE | 50,000 | $40.16 | $2,008,117.12 | -99.6% | |
| Aug 10, 2018 | John R Desjarlais74 | Sr. V.p., Research & CSO | Sale+OE | 35,000 | $40.36 | $1,412,721.13 | -28.4% | |
| Jul 17, 2018 | John S Stafford III46 | 10% Owner | Sell | 111,700 | $41.42 | $4,626,478.59 | -2.2% | |
| Jul 12, 2018 | John S Stafford III46 | 10% Owner | Sell | 138,300 | $39.69 | $5,489,265.18 | -2.6% |